Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-277996
Filing Date
2023-11-15
Accepted
2023-11-15 17:21:49
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12376
2 GRAPHIC g541146g31o61.jpg GRAPHIC 5082
3 GRAPHIC g541146g31t80.jpg GRAPHIC 8362
4 GRAPHIC g541146g97l17.jpg GRAPHIC 7724
  Complete submission text file 0001193125-23-277996.txt   42943
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)